AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
- Autores
- Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; Diamond, Michael S; Iwasaki, Akiko; Rothlin, Carla
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity.
Fil: Schmid, Edward T.. University of Yale; Estados Unidos
Fil: Pang, Iris K.. University of Yale; Estados Unidos
Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos
Fil: Bosurgi, Lidia. University of Yale; Estados Unidos
Fil: Miner, Jonathan J. Washington University School of Medicine; Estados Unidos
Fil: Diamond, Michael S. Washington University School of Medicine; Estados Unidos
Fil: Iwasaki, Akiko. University of Yale; Estados Unidos
Fil: Rothlin, Carla. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos - Materia
-
AXL
DENDRITIC CELLS
ANTIVIRAL RESPONSE
T CELL - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/53313
Ver los metadatos del registro completo
id |
CONICETDig_360cfa026eeac74d41f4485c21ac99fc |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/53313 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunitySchmid, Edward T.Pang, Iris K.Carrera Silva, Eugenio AntonioBosurgi, LidiaMiner, Jonathan JDiamond, Michael SIwasaki, AkikoRothlin, CarlaAXLDENDRITIC CELLSANTIVIRAL RESPONSET CELLhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity.Fil: Schmid, Edward T.. University of Yale; Estados UnidosFil: Pang, Iris K.. University of Yale; Estados UnidosFil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados UnidosFil: Bosurgi, Lidia. University of Yale; Estados UnidosFil: Miner, Jonathan J. Washington University School of Medicine; Estados UnidosFil: Diamond, Michael S. Washington University School of Medicine; Estados UnidosFil: Iwasaki, Akiko. University of Yale; Estados UnidosFil: Rothlin, Carla. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados UnidoseLife Sciences Publications2016-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/53313Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; et al.; AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity; eLife Sciences Publications; eLife; 5; 6-2016; 1-182050-084XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.12414info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/12414info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:44:06Zoai:ri.conicet.gov.ar:11336/53313instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:44:06.873CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
title |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
spellingShingle |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity Schmid, Edward T. AXL DENDRITIC CELLS ANTIVIRAL RESPONSE T CELL |
title_short |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
title_full |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
title_fullStr |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
title_full_unstemmed |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
title_sort |
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity |
dc.creator.none.fl_str_mv |
Schmid, Edward T. Pang, Iris K. Carrera Silva, Eugenio Antonio Bosurgi, Lidia Miner, Jonathan J Diamond, Michael S Iwasaki, Akiko Rothlin, Carla |
author |
Schmid, Edward T. |
author_facet |
Schmid, Edward T. Pang, Iris K. Carrera Silva, Eugenio Antonio Bosurgi, Lidia Miner, Jonathan J Diamond, Michael S Iwasaki, Akiko Rothlin, Carla |
author_role |
author |
author2 |
Pang, Iris K. Carrera Silva, Eugenio Antonio Bosurgi, Lidia Miner, Jonathan J Diamond, Michael S Iwasaki, Akiko Rothlin, Carla |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
AXL DENDRITIC CELLS ANTIVIRAL RESPONSE T CELL |
topic |
AXL DENDRITIC CELLS ANTIVIRAL RESPONSE T CELL |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity. Fil: Schmid, Edward T.. University of Yale; Estados Unidos Fil: Pang, Iris K.. University of Yale; Estados Unidos Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos Fil: Bosurgi, Lidia. University of Yale; Estados Unidos Fil: Miner, Jonathan J. Washington University School of Medicine; Estados Unidos Fil: Diamond, Michael S. Washington University School of Medicine; Estados Unidos Fil: Iwasaki, Akiko. University of Yale; Estados Unidos Fil: Rothlin, Carla. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos |
description |
The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/53313 Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; et al.; AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity; eLife Sciences Publications; eLife; 5; 6-2016; 1-18 2050-084X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/53313 |
identifier_str_mv |
Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; et al.; AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity; eLife Sciences Publications; eLife; 5; 6-2016; 1-18 2050-084X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.12414 info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/12414 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
eLife Sciences Publications |
publisher.none.fl_str_mv |
eLife Sciences Publications |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613388033851392 |
score |
13.070432 |